Hormone replacement therapy with transdermal estradiol gel and oral progesterone: Effects of menopausal symptoms and lipid metabolism;Die hormonersatztherapie mit einem perkutan wirksamen oestradiol-gel und oral verabreichtem mikronisierten progesteron. Auswirkung auf klimakterische symptome und den lipidstoffwechsel

Wiener Klinische Wochenschrift

Volumn 112, Issue 14, 2000, Pages 629-633

  Giuliani, A ^a   Concin, H ^a   Wieser, F ^a   Boritsch, J ^a   Wilfert, H ^a   Gruber, D ^a   Urdl, W ^a  

^a Geburtshilflich Gynakologische Universitats Klinik   (Austria)

Author keywords

17 estradiol; Hormone replacement therapy; Lipoprotein (a); Progesterone; Total cholesterol

Indexed keywords

CHOLESTEROL; ESTRADIOL; LIPOPROTEIN; PROGESTERONE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GEL; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MENOPAUSAL SYNDROME; MULTICENTER STUDY; SCORING SYSTEM;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; CHOLESTEROL; DRUG CARRIERS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); LIPOSOMES; MENOPAUSE; MIDDLE AGED; PATIENT SATISFACTION; PROGESTERONE; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0034725953     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Comparative effects of percutaneous estradiol and conjugated estrogens as replacement therapy in postmenopausal women
2. Menopause and risk factors for coronary heart disease
3. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
4. Comparative clinical evaluation of estrogen preparations by the menopausal and amenorrhoeal indices
5. Biological effects of estradiol 17B in postmenopausal women: Oral versus percutaneous administration
6. Hormonersatztherapie mit 17β-Ostradiol-Dydrogesteron: Ergebnisse einer dreimonatigen Anwendungsbeobachtung
7. Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol
8. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study)
9. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women
10. Effects of hormone replacement therapy on endometrial histology in postmenopausal women
11. Hepatic lipase activity during oral and parenteral 17B-estradiol replacement therapy
12. Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women
13. Minimal levels of serum estradiol prevent postmenopausal bone loss
14. The effect of percutaneous estradiol and natural progesterone on postmeno-pausal bone loss
15. Can climacteric women self-adjust therapeutic estrogen doses using symptoms as markers